Rhythm Pharmaceuticals (RYTM) total liabilities

Total liabilities · fiscal 2025
$210.17M

Rhythm Pharmaceuticals (RYTM) had total liabilities of $210.17M at the end of fiscal 2025 (December 31, 2025). That is 7.7% lower than the $227.72M of fiscal 2024. Figures as of 19 Nov 2026, 11:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$210.17M
Change on fiscal 2024
−7.7%
Growth, 5 years
+59.2% a year
Highest on record
$227.72Mfiscal 2024
Lowest on record
$5.04Mfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Rhythm Pharmaceuticals total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 59.2% a year. Across the 10 fiscal years on record (2016–2025), the highest was $227.72M in fiscal 2024 and the lowest $5.04M in fiscal 2016.

History · 10 fiscal years

Total liabilities by fiscal year

Rhythm Pharmaceuticals total liabilities, year by year

Rhythm Pharmaceuticals (RYTM) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$210.17M 7.7% down
2024$227.72M 39.7% up
2023$162.99M 37.9% up
2022$118.22M 160.6% up
2021$45.37M 120.8% up
2020$20.55M 25.3% down
2019$27.50M 97.1% up
2018$13.95M 100.8% up
2017$6.95M 37.8% up
2016$5.04M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Rhythm Pharmaceuticals and comparable companies
CompanyTotal liabilitiesFiscal year
Rhythm Pharmaceuticals RYTM$210.17M2025
Alkermes ALKS$667.70M2025
PACS Group PACS$4.63B2025
Kiniksa Pharmaceuticals International KNSA$196.03M2025
ImmunityBio IBRX$1.00B2025
Cytokinetics CYTK$2.08B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RYTM

Rhythm Pharmaceuticals, figure by figure

Rhythm Pharmaceuticals (RYTM) overview: price, valuation and scorecardAll health care companies by market value

Rhythm Pharmaceuticals total liabilities: questions and answers

How large are Rhythm Pharmaceuticals's total liabilities?

Rhythm Pharmaceuticals (RYTM) had total liabilities of $210.17M at the end of fiscal 2025 (December 31, 2025). That is 7.7% lower than the $227.72M of fiscal 2024.

What is the growth rate of Rhythm Pharmaceuticals's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 59.2% a year.

What are the highest and lowest total liabilities figures on record for Rhythm Pharmaceuticals?

Across the 10 fiscal years on record (2016–2025), the highest was $227.72M in fiscal 2024 and the lowest $5.04M in fiscal 2016.

How is Rhythm Pharmaceuticals's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Rhythm Pharmaceuticals it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Rhythm Pharmaceuticals (RYTM) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/RYTM/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.